Content about Kathleen Jaeger

March 3, 2011

The National Association of Chain Drug Stores and the National Community Pharmacists Association have expressed their support for H.R. 891, the Medication Therapy Management Benefits Act of 2011.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores and the National Community Pharmacists Association have expressed their support for H.R. 891, the Medication Therapy Management Benefits Act of 2011, as it would expand the pool of Medicare Part D beneficiaries who can qualify for the service provided by a licensed pharmacist to any patient with a chronic medical condition. Currently, only those patients suffering from multiple chronic conditions are eligible.

Reps. Cathy McMorris Rodgers, R-Wash., and Mike Ross, D-Ark., introduced the bill.

February 18, 2011

The National Association of Chain Drug Stores and the National Community Pharmacists Association on Friday sent a joint letter to every governor and state Medicaid director on the importance of pharmacies in Medicaid and the industry’s interest in working with state governments to cut costs.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores and the National Community Pharmacists Association on Friday sent a joint letter to every governor and state Medicaid director on the importance of pharmacies in Medicaid and the industry’s interest in working with state governments to cut costs.

February 3, 2011

The National Community Pharmacists Association expressed its support of the Senate's decision to repeal the 1099 tax reporting mandate for businesses.

ALEXANDRIA, Va. — The National Community Pharmacists Association expressed its support of the Senate's decision to repeal the 1099 tax reporting mandate for businesses.

The Senate announced it passed an amendment that repealed a requirement for businesses to file 1099 forms with the Internal Revenue Service beginning in 2012 any time they spend more than $600 a year with any other business. NCPA EVP and CEO Kathleen Jaeger said that the business tax provision would have shifted community pharmacies focus from "clinical to clerical."

February 1, 2011

Years 2009 and 2010 were up and down for the generic drug industry and its main trade group, the Generic Pharmaceutical Association. On one hand, there were the departures of president and CEO Kathleen Jaeger and member company Teva Pharmaceutical Industries.

January 11, 2011

The nation’s top independent pharmacy group is hailing a recent decision by a major corporation to maintain freedom of choice of where its employees fill their maintenance prescription medicines.

ALEXANDRIA, Va. — The nation’s top independent pharmacy group is hailing a recent decision by a major corporation to maintain freedom of choice of where its employees fill their maintenance prescription medicines.

The National Community Pharmacists Association today applauded BB&T's decision to reemphasize and continue its employees' choice in filling their maintenance prescriptions, including at independent community pharmacies. The revised policy was communicated to BB&T employees last week.

January 5, 2011

ALEXANDRIA, Va. — Congress handed community pharmacies a Christmas present in December, voting to exempt them from burdensome accounting requirements imposed by the Federal Trade Commission.


December 20, 2010

A study by the Government Accountability Office confirmed that the health-reform law enacted earlier this year established a more reasonable reimbursement level for pharmacies dispensing generic drugs to patients covered by Medicaid. But pharmacy retailers still face the continued threat of further Medicaid cuts at the state level, the independent pharmacy lobby warned Friday.

ALEXANDRIA, Va. — A study by the Government Accountability Office confirmed that the health-reform law enacted earlier this year established a more reasonable reimbursement level for pharmacies dispensing generic drugs to patients covered by Medicaid. But pharmacy retailers still face the continued threat of further Medicaid cuts at the state level, the independent pharmacy lobby warned Friday.

December 14, 2010

In a clear victory for retail pharmacy, the National Association of Chain Drug Stores and the National Community Pharmacists Association have agreed with the Centers for Medicare and Medicaid Services on a motion to dismiss the Medicaid average manufacturer price lawsuit.

ALEXANDRIA, Va. — In a clear victory for retail pharmacy, the National Association of Chain Drug Stores and the National Community Pharmacists Association have agreed with the Centers for Medicare and Medicaid Services on a motion to dismiss the Medicaid average manufacturer price lawsuit. The landmark agreement came after CMS withdrew the last remaining provisions of the AMP rule that had been blocked by a preliminary injunction following litigation by NACDS and NCPA.

November 24, 2010

More than ever, seniors who rely on Medicare need to carefully evaluate the dizzying array of prescription drug plan choices available to them, as the 2011 enrollment period for Medicare Part D drug benefit program goes into high gear, independent pharmacy leaders declared Tuesday.

ALEXANDRIA, Va. — More than ever, seniors who rely on Medicare need to carefully evaluate the dizzying array of prescription drug plan choices available to them, as the 2011 enrollment period for Medicare Part D drug benefit program goes into high gear, independent pharmacy leaders declared Tuesday.

November 15, 2010

The Centers for Medicare and Medicaid Services has proposed a rule shortening the traditional 30-day...

ALEXANDRIA, Va. — The Centers for Medicare and Medicaid Services has proposed a rule shortening the traditional 30-day drug cycle for long-term care centers to seven days when brand-name drugs are dispensed, prompting a supportive response from an organization representing independent pharmacies.

 

November 14, 2010

The natural affinity that has sprung up between independent pharmacy and the generic drug industry—both...

ALEXANDRIA, Va. — The natural affinity that has sprung up between independent pharmacy and the generic drug industry — both viewed as underdogs in the relentless fight for market position and profits: one versus powerful chain and big-box retailers, the other versus the far more entrenched and well-funded branded drug industry — was never more fully realized than it was at the end of October, when the National Community Pharmacists Association introduced its new top manager to its members at the group’s annual meeting.

October 28, 2010

The natural affinity that has sprung up between independent pharmacy and the generic drug industry...

WHAT IT MEANS AND WHY IT'S IMPORTANT The natural affinity that has sprung up between independent pharmacy and the generic drug industry -- both viewed as underdogs in the relentless fight for market position and profits: one versus powerful chain and big-box retailers, the other versus the far more entrenched and well-funded branded drug industry -- was never more fully realized than it was last weekend, when the National Community Pharmacists Association introduced its new top manager to its members at the group’s annual meeting.

October 24, 2010

Independent pharmacies in 2009 generally were able to withstand the pummeling of a major recession,...

October 24, 2010

In a highly anticipated move to new leadership, the National Community Pharmacists Association has named...

September 26, 2010

For all its successes, the generic drug industry has had a lot to worry about...

June 6, 2010

After nearly a decade at the helm, Generic Pharmaceutical Association president and CEO Kathleen Jaeger...

May 3, 2010

Generic Pharmaceutical Association president and CEO Kathleen Jaeger will leave the organization effective June 30,...

April 16, 2009

A report by AARP indicated that prices for branded drugs have increased at a rate...

NEW YORK A report by AARP indicated that prices for branded drugs have increased at a rate outpacing the rate of inflation by more than six percentage points.

 

The report found that manufacturers’ prices for branded drugs increased by 9% last year, compared with the general inflation rate of 3.8%. Meanwhile, prices of generic drugs decreased, on average, by 10.6%.